Podcast Episodes
Back to Search
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
Episode 214
In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-n…
8 months, 2 weeks ago
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Episode 213
In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-n…
8 months, 2 weeks ago
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
Episode 212
In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with H…
8 months, 2 weeks ago
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
Episode 211
In this episode, Dr Christopher Flowers and Dr John Allan discuss their experience with the use of CD20xCD3 bispecific antibodies in the treatment of…
9 months, 2 weeks ago
Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients
Episode 210
Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic canc…
9 months, 3 weeks ago
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma
Episode 209
In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myelo…
9 months, 3 weeks ago
CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Experts Answer Your Questions
Episode 206
In this episode, Drs William J. Gradishar, Heather McArthur, and Joanne Mortimer address audience questions from a recent live event on the use of CD…
10 months ago
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
Episode 208
In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmo…
10 months, 2 weeks ago
Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
Episode 207
In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging …
10 months, 2 weeks ago
Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025
Episode 205
In this podcast, Max S. Topp, MD, and Pier Luigi Zinzani, MD, PhD, explore the current and future implications of some of their top choices of studie…
11 months ago